Medtronic achieves ce mark approval for brainsense™ adaptive deep brain stimulation and electrode identifier, a groundbreaking advance in personalized, sensing-enabled care for people with parkinson's through innovative brain-computer interface technology

European approval introduces the world's only closed-loop dbs system with real-time, self-adjusting brain stimulation for people with parkinson's disease galway, ireland , jan. 13, 2025 /prnewswire/ -- medtronic plc (nyse:mdt), a global leader in healthcare technology, announced today ce (conformitÉ europÉenne) mark approval in the european union (eu) and the united kingdom (uk) for brainsense™ adaptive deep brain stimulation (adbs) and brainsense™ electrode identifier (ei), having achieved the standards required by the eu medical device regulation (mdr). in addition, the first programming was completed today, performed by martijn beudel, md, phd, neurologist and associate professor, department of neurology, amsterdam university medical center.
MDT Ratings Summary
MDT Quant Ranking